XMTR.NASDAQXometry, INC

Form 4: Xometry CSO Sells Shares Under Pre-Arranged 10b5-1 Plan

Sentiment:

Insider Transaction Report


Xometry's Chief Sales Officer, Subir Dutt, executed a pre-arranged sale of 2,500 shares of Class A Common Stock at $70 per share.

Summary

  • Subir Dutt, Chief Sales Officer of Xometry, Inc. (XMTR), reported a sale of 2,500 shares of Class A Common Stock.
  • The transaction occurred on February 9, 2026, with a sale price of $70 per share.
  • Following this transaction, Subir Dutt beneficially owns 64,919 shares of Class A Common Stock.
  • The sale was executed automatically pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person at least 90 days prior to the trading date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it is an insider sale, the execution under a pre-arranged 10b5-1 plan mitigates any immediate negative sentiment, as it reflects planned personal financial management rather than a reaction to new company-specific information.

Positives

  • The transaction was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale rather than a discretionary one based on immediate market sentiment, which can reduce concerns about insider timing.

Negatives

  • An insider sale, even if pre-planned, reduces the officer's direct equity stake in the company, which some investors might interpret as a slight reduction in alignment of interests.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common practice for executives to manage personal finances while adhering to insider trading regulations. For Xometry, a company operating in the on-demand manufacturing marketplace, such a routine sale by a Chief Sales Officer does not inherently signal a change in the company's operational trajectory or market position, but rather a pre-planned liquidity event.

Comparison to Industry Standards

  • Insider sales under 10b5-1 plans are a standard practice across publicly traded companies, including those in the technology and manufacturing sectors like Xometry. These plans are designed to allow insiders to sell shares without being accused of trading on material non-public information.
  • The volume of shares sold (2,500 shares) represents a small fraction of the officer's total holdings (64,919 shares remaining), which is typical for routine liquidity management rather than a significant divestment.

Stakeholder Impact

  • Shareholders: The sale by a Chief Sales Officer could be viewed with slight caution, but the 10b5-1 plan context generally alleviates concerns about negative insider sentiment. The remaining significant holding indicates continued alignment.
  • Employees: No direct impact on employees is indicated by this filing.

Key Dates

DateDescription
02/09/2026Date of transaction for the sale of Class A Common Stock.
02/11/2026Date the Form 4 was signed by the reporting person's attorney-in-fact.

Recommendation

hold

The insider sale, while a reduction in direct ownership, was executed under a pre-arranged 10b5-1 plan, which is a routine financial management tool for executives. It does not provide new material information about the company's operational performance or future prospects that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive company updates.

Keywords

Xometry, XMTR, Insider Trading, Form 4, Subir Dutt, Chief Sales Officer, Stock Sale, 10b5-1 Plan, Equity, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.